Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Amplify Weight Loss Drug & Treatment ETF (THNR)

Amplify Weight Loss Drug & Treatment ETF (THNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR Zacks Investment Research - Thu Oct 17, 8:10AM CDT

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 105.27 (+2.57%)
LLY : 753.41 (+3.25%)
HRTS : 30.88 (+1.28%)
PPH : 87.44 (+0.66%)
THNR : 23.17 (+1.32%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win Zacks Investment Research - Wed Oct 16, 2:02PM CDT

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 105.27 (+2.57%)
LLY : 753.41 (+3.25%)
HRTS : 30.88 (+1.28%)
PPH : 87.44 (+0.66%)
THNR : 23.17 (+1.32%)
Tap the Weight-Loss Drug Market With These ETFs
Tap the Weight-Loss Drug Market With These ETFs Zacks Investment Research - Wed Sep 18, 11:15AM CDT

The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other companies are...

RHHBY : 35.1300 (-0.79%)
NVO : 105.27 (+2.57%)
LLY : 753.41 (+3.25%)
HRTS : 30.88 (+1.28%)
THNR : 23.17 (+1.32%)
OZEM : 25.57 (+2.16%)

Barchart Exclusives

Stocks Muted Before the Open With U.S. Economic Data in Focus, Nvidia Slips on Disappointing Forecast Barchart - 1 hour ago
December S&P 500 E-Mini futures (ESZ24) are up +0.04%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.09% this morning as investors looked ahead to a raft of U.S. economic data that could provide insights into the Federal Reserve's decision-making on monetary policy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot